Olfactory sensitivity. Functioning in schizophrenia and implications for understanding the nature and progression of psychosis

Vitamins and Hormones

Volumn 83, Issue C, 2010, Pages 305-329

  Brewer, Warrick J ^b   Pantelis, Christos ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Olfactory acuity; Orbitofrontal cortex; Psychosis

Indexed keywords

BOOK; HUMAN; OLFACTORY RECEPTOR; PATHOPHYSIOLOGY; PHYSIOLOGY; PSYCHOSIS; SCHIZOPHRENIA; SMELLING; SMELLING DISORDER;

HUMANS; OLFACTION DISORDERS; OLFACTORY PERCEPTION; OLFACTORY RECEPTOR NEURONS; PSYCHOTIC DISORDERS; SCHIZOPHRENIA;

EID: 77956444540     PISSN: 00836729     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0083-6729(10)83013-4     Document Type: Book

References (112)

1. Adams R., Victor M. Principles of Neurology 1985, McGraw Hill, New York.
2. Albone E.S., Shirley S.G. Mammalian Semiochemistry. The Investigation of Chemical Signals Between Mammals 1984, New York, John Wiley.
3. Amoore J.E. Molecular Basis of Odor 1970, Thomas, Illinois.
4. Beauchamp G.K., Pearson P. Human development and taste. Phsysiol. Behav. 1991, 49:1009-1012.
5. Beets M.G.J., Theimer T. Odours similarity between structurally unrelated odorants. Taste and Smell in Vertebrates 1970, Churchill, London. G.E.W. Wolstenhome, J. Knights (Eds.).
6. Berliner D.L., Jennings-White C., Lavker R.M. The human skin: Fragrances and pheromones. J. Steroidal Biochem. Mol. Biol. 1991, 39(4B):671-679.
7. Bertollo D.N., Cowen M.A., Levy A.V. Hypometabolism in olfactory cortical projection areas of male patients with schizophrenia: An initial positron emission tomography study. Psychiatry Res. 1996, 60:13-116.
8. Bird S., Gower D.B. Axillary 5-alpha-androst-16-en-3-one, cholesterol and squalene in men: Preliminary evidence for 5-alpha-androst-16-en-3-one being a product of bacterial action. J. Steroidal Biochem. 1982, 17:517-522.
9. Bleuler M. Endokrinologische Psychiatrie 1954, Thieme, Stuttgart.
10. Bradley E.A. Olfactory acuity to a pheromonal substance and psychotic illness. Biol. Psychiatry 1984, 19:899-905.
11. Brewer W.J., Castle D., Pantelis C. Olfaction and the Brain. 2006, Cambridge University Press, Melbourne.
12. Brewer W.J., Edwards J., Anderson V., Robinson T., Pantelis C. Neuropsychological, olfactory, and hygiene deficits in men with negative symptom schizophrenia. Biol. Psychiatry 1996, 40:1021-1031.
13. Brewer W.J., Pantelis C., Anderson V., Velakoulis D., Singh B., Copolov D.L., et al. Stability of olfactory identification deficits in neuroleptic-naive patients with first episode psychosis. Am. J. Psychiatry 2001, 158:107-115.
14. Brewer W.J., Wood S.J., McGorry P.D., Francey S.M., Phillips L.J., Yung A., et al. Impaired olfactory identification in individuals at ultra-high risk for psychosis who later develop schizophrenia. Am. J. Psychiatry 2003, 160:1790-1794.
15. Brewer W.J., Pantelis C., De Luca C., Wood S.J. Olfactory processing and brain maturation. Olfaction and the Brain 2006, Cambridge University Press, New York. W. Brewer, D. Castle, C. Pantelis (Eds.).
16. Brewer W.J., Wood S.J., Pantelis C., Berger G., Copolov D.L., McGorry P.D. Olfactory sensitivity through the course of psychosis: Relationships to olfactory identification, symptomatology and the schizophrenia odour. Psychiatry Res. 2007, 149:97-104.
17. Brooksbank B.W.L. Urinary excretion of androst-16-en-3-alpha-ol levels in normal subjects, and effects of treatment with trophic hormones. J. Endocrinol. 1962, 24:435-444.
18. Brooksbank B.W.L., Pryse-Phillips W. Urinary alpha-16-androsten-3alpha-ol, 17-oxosteroids and mental illness. BMJ 1964, 20:1602-1606.
19. Brooksbank B.W.L., Brown R., Gustafsson J.A. The detection of 5-alpha-androst-16-en-3alpha-ol in human male axillary sweat. Experientia 1974, 30(8):864-865.
20. Broverman D.M., Klaiber E.L., Kobayahi Y., Vogel W. Roles of activation and inhibition in sex differences in cognitive abilities. Psychol. Rev. 1968, 75:23-50.
21. Cain W.S., Stevens J.C., Nickou C., et al. Life-span development of odor identification, learning and olfactory sensitivity. Perception 1995, 24:1457-1472.
22. Charney W. Transformation of steroids by corynebacteriaceae. J. Appl. Bacteriol. 1966, 29:93-106.
23. Clark T.O., Ball R Sensitivities to five putative human pheromones in a population of young male service recruits. Mimeograph 1983, 80. From Pharmabulletin, Health Commission of Victoria: Publisher.
24. Claus R., Alsing W. Occurrence of 5-alpha-androst-16-en-3-one, a boar pheromone, in man and its relationship to testosterone. J. Endocrinol. 1976, 68:483-484.
25. Compton M.T., McKenzie Mack L., Esterberg M.L., Bercu Z., Kryda A.D., Quintero L., Weiss P.S., Walker E.F. Associations between olfactory identification and verbal memory in patients with schizophrenia, first-degree relatives, and non-psychiatric controls. Schizophr. Res. 2006 Sep, 86(1-3):154-166. [Epub 2006 Jul 17].
26. Corcoran C., Whitaker A., Coleman E., Fried J., Feldman J., Goudsmit N., Malaspina D. Olfactory deficits, cognition and negative symptoms in early onset psychosis. Schizophr. Res. 2005 Dec 15, 80(2-3):283-293. [Epub 2005 Aug 26].
27. Dorries K.M., Schmidt H.J., Beauchamp G.K., et al. Changes in sensitivity to the odor of androstenone during adolescence. Dev. Psychobiol. 1989, 22:423-425.
28. Doty R. Chemical communication on sex and reproductive state in humans. Chemical Signals in Vertebrates 1977, 273-286. Plenum Press, New York. D. Muller-Schwarze, M.M. Mozell (Eds.).
29. Doty R., Shaman P., Dann W. Development of the University of Pennsylvania Smell Test: Standardised micro-encapsulated test of olfactory function. Physiol. Behav. 1984, 32:489-502.
30. Eslinger P.J., Damasio A.R., Van Hoesen G.W. Olfactory dysfunction in man: Anatomical and behavioral aspects. Brain Cogn. 1982 Jul, 1(3):259-285.
31. Geddes J., Huws R., Pratt P. Olfactory acuity in the positive and negative symptoms of schizophrenia. Biol. Psychiatry 1991, 29:774-778.
32. Good K.P., Whitehorn D., Rui Q., Milliken H., Kopala L.C. Olfactory identification deficits in first-episode psychosis may predict patients at risk for persistent negative and disorganized or cognitive symptoms. Am. J. Psychiatry. 2006 May, 163(5):932-933.
33. Gower D.B., Bicknell D.C. Steroid excretion and biosynthesis, with special reference to 16-unsaturated C 19 steroids, in cases of testicular feminization and in a male pseudohermaphrodite. Acta Endocrinol. 1972, 70:567-581.
34. Gower D.B., Bird P.S., House F.R. Axillary 5-alpha-androst-16-en-3-one in men and women: Relationships with olfactory acuity to odorous 16-androstenes. Experientia 1985, 41:1134-1136.
35. Greer F.R., Marshall S., Cherry J., Suttie J.W. Vitamin K status of lactating mothers, human milk, and breast-feeding infants. Pediatrics. 1991 Oct, 88(4):751-756.
36. Griffiths N., Patterson R. Human olfactory responses to 5-alpha-androst-16-en-3-one: Principle component of boar taint. J. Sci. Food Agric. 1970, 21:4-6.
37. Gross-Isseroff R., Luca-Haimovici K., Sasson Y., Kindler S., Zohar J. Olfactory sensitivity in major depressive disorder and obsessive compulsive disorder. Biol. Psychiatry 1994, 53:798-802.
38. Hampson E., Kimura D. Sex differences and hormonal influences on cognitive function in humans. Behavioral Endocrinology 1992, MIT Press. J.B. Becker, S.M. Breedlove, D. Crews (Eds.).
39. Harrison P.J., Pearson R.C.A. Olfaction and psychiatry. Br. J. Psychiatry 1989, 155:822-828.
40. Hubert H.B., Fabsitz R.R., Feinlab M., Brown K.S. Science 1980, 208:608-609.
41. Hubert H.B., Fabsitz R.R., Brown K.S., Feinlab M. Twin Research 3: Epidemiological and Clinical Studies 1981, 97-103. Liss, New York. L. Gedda, P. Parise, W.E. Nance (Eds.).
42. Isseroff R.G., Stoler M., Ophir D., Lancet D., Sirota P. Olfactory sensitivity to androstenone in schizophrenic patients. Biol. Psychiatry 1987, 22:922-925.
43. Jackman P.J.H. Taxonomy of Aerobic Axillary Coryneforms Based on Electrophoretic Protein Patterns 1982, Unpublished PhD Thesis, University of London.
44. Jackman P.J.H., Noble W.C. Normal axillary skin microflora in various populations. Clin. Exp. Dermatol. 1983, 8:259-268.
45. Jackson H.J. Negative Symptoms and Social Skills Performance in Schizophrenia 1987, Unpublished Thesis for Master of Arts Degree, University of Melbourne, Victoria.
46. Jones-Gotman M. Localisation of lesions by neuropsychological testing. Epilepsia 1991, 32(Supp. 5):S41-S52.
47. Jones-Gotman M., Zatorre R.J. Olfactory identification deficits in patients with focal cerebral excision. Neuropsychologia 1988, 26:387-400.
48. Kandel E.R., Schwartz J.H., Jessell T.M. Principles of Neural Science 1991, Elsevier, London. 3rd edn.
49. Kloek J. The smell of some steroid sex-hormones and their metabolites. Psychiatry, Neurol. Neurochem. 1961, 64:309-344.
50. Kloos W.E., Musselwhite M.S. Distribution and persistence of staphylococcus and micrococcus species and other aerobic bacteria on human skin. Appl. Microbiol. 1975, 30:381-395.
51. Koelega H.S. Prepubescent children may have specific deficits in olfactory sensitivity. Percep. Motor Skills 1994, 78:191-199.
52. Koelega H.S., Koster E.P. Some experiments on sex differences in odor perception. Ann. NY Acad. Sci. 1974, 237:234-246.
53. Kopala L., Clark C. Implications of olfactory agnosia for understanding sex differences in schizophrenia. Schizophr. Bull. 1990, 16:255-261.
54. Kopala L., Clark C., Hurwitz T.A. Sex differences in olfactory function in schizophrenia. Am. J. Psychiatry 1989, 146:1320-1322.
55. Kopala L., Clark C., Hurwitz T. Olfactory deficits in neuroleptic naive patients with schizophrenia. Schizophr. Res. 1992, 8:245-250.
56. Kopala L.C., Good K.P., Honer W.G. Olfactory hallucinations and olfactory identification ability in patients with schizophrenia and other psychiatric disorders. Schizophr. Res. 1994, 12:205-211.
57. Kopala L.C., Good K.P., Honer W.G. Olfactory identification ability in pre- and postmenopausal women with schizophrenia. Biol. Psychiatry 1994, 38:57-63.
58. Kopala L.C., Good K., Martzke J., Hurwitz T. Olfactory deficits in schizophrenia are not a function of task complexity. Schizophr. Res. 1995, 17:195-199.
59. Kopala L.C., Good K.P., Koczapski A.B., Honer W.G. Olfactory deficits in patients with schizophrenia and severe polydipsia. Biol. Psychiatry 1998, 43:497-502.
60. Kopala L.C., Good K.P., Morrison K., Bassett A.S., Alda M., Honer W.G. Impaired olfactory identification in relatives of patients with familial schizophrenia. Am. J. Psychiatry. 2001 Aug, 158(8):1286-1290.
61. Larsson M., Backman L. Age-related differences in episodic odour recognition: The role of access to specific odour names. Memory 1997, 5(3):361-378.
62. Le Magnen J. Les phenomenes olfacto-sexuels chez le rat blanc. Arch. Sci. Physiol. (Paris) 1952, 6:295-332.
63. Leydon J.J., McGinley K.J., Holzle E., Labows J.N., Kligman A.M. The microbiology of the human axilla and its relationship to axillary odor. J. Invest. Dermatol. 1981, 77:413-416.
64. Liddell K. Smell as a diagnostic marker. Postgrad. Med. J. 1976, 52:136-138.
65. Malaspina D., Coleman E. Olfaction and social drive in schizophrenia. Arch. Gen. Psychiatry. 2003 Jun, 60(6):578-584.
66. Martzke J.S., Kopala L.C., Good K.P. Olfactory dysfunction in neuropsychiatric disorders: Review and methodological considerations. Biol. Psychiatry 1997, 42:721-732.
67. McGlashan T.H., Hoffman R.E. Schizophrenia as a disorder of developmentally reduced synaptic connectivity. Arch. Gen. Psychiatry. 2000 Jul, 57(7):637-648.
68. Melrose D.R., Reed H.C.B., Patterson R.L.S. Androgen steroids associated with boar odour as an aid to the detection of oestrus in pig artificial insemination. Br. Vet. J. 1971, 127:497-502.
69. Moberg P.J., Agrin R., Gur R.E., Gur R.C., Turetsky B.I., Doty R.L. Olfactory dysfunction in schizophrenia: A qualitative and quantitative review. Neuropsychopharmacol 1999, 21:325-340.
70. Moberg P.J., Arnold S.E., Doty R.L., Gur R.E., Balderston C.C., Roalf D.R., Gur R.C., Kohler C.G., Kanes S.J., Siegel S.J., Turetsky B.I. Olfactory functioning in schizophrenia: Relationship to clinical, neuropsychological, and volumetric MRI measures. J. Clin. Exp. Neuropsychol. 2006 Nov, 28(8):1444-1461.
71. Moberg P.J., Roalf B.S., GUr R.E., Turetsky B.I. Smaller nasal volumes as stigmata of aberrant neurodevelopment in schizophrenia. Am. J. Psychiatry 2004, 161:2314-2316.
72. Mozley P.D., Stubbs J.B., Kim H.J., McElgin W., Chumpradit S., Kung M.P., Romaniello G., Kung H.F. Dosimetry of a D2/D3 dopamine receptor antagonist that can be used with PET or SPECT. J. Nucl. Med. 1995 Jul, 36(7):1322-1331.
73. Pantelis C., Brewer W.J. Neuropsychological and olfactory dysfunction in schizophrenia: Relationship of frontal syndromes to syndromes of schizophrenia. Schizophr. Res. 1995, 17:35-45.
74. Pantelis C., Brewer W.J. Neurocognitive and neurobehavioral patterns and the syndromes of schizophrenia: Role of frontal-subcortical networks. Schizophrenia: A Neuropsychological Perspective 1996, 317-343. John Wiley & Sons, Chichester. C. Pantelis, H.E. Nelson, T.R.E. Barnes (Eds.).
75. Pantelis C., Barnes T.R.E., Nelson H.E. Is the concept of frontal-subcortical dementia relevant to schizophrenia?. Br. J. Psychiatry 1992, 160:442-460.
76. Potter H., Butters N. An assessment of olfactory deficits in patients with damage to prefrontal cortex. Neuropsychologia 1980, 18:621-628.
77. Qureshy A., Kawashima R., Imran M.B., Sugiura M., Goto R., Okada K., Inoue K., Itoh M., Schormann T., Zilles K., Fukuda H. Functional mapping of human brain in olfactory processing: A PET study. J. Neurophysiol. 2000 Sep, 84(3):1656-1666.
78. Rausch R., Serafetinides E.A. Specific alterations of olfactory function in humans with temporal lobe lesions. Nature 1975, 255:557-558.
79. Reiss M. Psychoendocrinology 1958, Grune and Stratton, New York.
80. Rennie P.J., Gower D.B., Holland K.T. In vitro and in vivo studies of human axillary odor and the cutaneous micro-flora. Br. J. Dermatol. 1991, 124:596-602.
81. Richman R.A., Post E.M., Sheehe P.R., et al. Olfactory performance during childhood I. Development of an odourant identification test for children. J. Pediatr. 1992, 121:908-911.
82. Sands D.E. Schizophrenia: Somatic Aspects 1957, 77. Pergamon, London. D. Richter (Ed.).
83. Schall B. Olfaction in infants and children: Developmental and functional perspectives. Chem. Senses 1988, 13:145-190.
84. Schall B., Marlier L., Soussignan R. Olfactory function in the human fetus: Evidence from selective neonatal responsiveness to the odor of amniotic fluid. Behav. Neurosci. 1998, 112(6):1438-1449.
85. Schneider F., Habel U., Reske M., Toni I., Falkai P., Shah J. Neural substrates of olfactory processing in schizophrenia patients and their healthy relatives. Psychiatry Res. 2007, 155:103-112.
86. Schneider R.A. Newer insights into the role and modification of olfaction in man through clinical studies. Ann. NY Acad. Sci. 1971, 237:217-223.
87. Seidman L.J., Talbot N.L., Kalinowski A.G., McCarley R.W., Faraone S.V., Kremen W.S., Pepple J.R., Tsuang M.T. Neuropsychological probes of fronto-limbic system dysfunction in schizophrenia: Olfactory identification and Wisconsin Card Sorting performance. Schizophr. Res. 1992, 6:55-65.
88. Seidman L.J., Yurgelun-Todd D., Kremen W.S., Woods B.T., Goldstein J.M., Faraone S.V., Tsuang M.T. Relationship of prefrontal and temporal lobe MRI measures to neuropsychological performance in chronic schizophrenia. Biol. Psychiatry 1994, 35:235-246.
89. Serby M. Odor detection in schizophrenia: Alternative explanations. Am. J. Psychiatry 2009, 166:727. (Letter to the Editor).
90. Serby M., Larson P., Kalkstein D. Olfactory senses in psychoses. Biol. Psychiatry 1990, 28:829-830.
91. Shehadeh N., Kligman A.M. The bacteria responsible for axillary odour. II. J. Invest. Dermatol. 1963, 41:3.
92. Skinner K., Smith K., Rich E. Bacteria and the "schizophrenic odor". Arch. Gen. Psychiatry 1964, 64. Abstracts.
93. Smith K., Sines J.O. Demonstration of a peculiar odour in the sweat of schizophrenic patients. Arch. Gen. Psychiatry 1960, 2:184-188.
94. Smith K., Thompson G.F., Koster H.D. Sweat in schizophrenic patients: Identification of odorous substance. Science 1969, 166:398-399.
95. Snowdon J. Uncleanliness among persons seen by community health workers. Hosp. Commun. Psychiatry 1987, 38(5):491-495.
96. Stoddart D.M. Mammalian Odours and Pheromones 1976, Camelot Press, Southampton.
97. Strauss E.L. A study on olfactory acuity. Ann. Otol. Rhinol. Laryngol. 1970, 79(1):95-104.
98. Trimble M.R. The neurology of schizophrenia. Br. Med. Bull. 1987, 43:616-633.
99. Turetsky B.I., Moberg P.J. An odor-specific threshold deficit implicates abnormal intracellular cyclic AMP signalling in schizophrenia. Am. J. Psychiatry 2009, 166:226-233.
100. Turetsky B.I., Moberg P.J. Letter to the Editor (Reply). Am. J. Psychiatry 2009, 166:728.
101. Turetsky B.I., Kohler C.G., Gur R.E., Moberg P.J. Olfactory physiological impairment in first-degree relatives of schizophrenia patients. Schizophr. Res. 2008, 102:220-229.
102. Turetsky B.I., Crutchley P.C., Walker J., Gur R.E., Moberg P.J. Depth of the olfactory sulcus: A marker of early embryonic disruption in schizophrenia?. Schizophr. Res. 2009, 115:8-11.
103. Turetsky B.I., Hahn C., Borgmann-Winter K., Moberg P.J. Scents and nonsense: Olfactory dysfunction in schizophrenia. Schizophr. Bull. 2009, 35(6):1117-1131.
104. Van Toller C., Kirk-Smith M., Wood N., Lombard J., Dodd G.H. Skin conductance and subjective assessments associated with the odour of 5-alpha-androstanon-3-one. Biol. Psychiatry 1983, 16:85-107.
105. Varney N.R. Prognostic significance of anosmia in patients with closed-head trauma. J. Clin. Exp. Neuropsychol. 1988, 10(2):250-254.
106. Wiener H. External chemical messengers. I. Emission and reception in man. NY State J. Med. 1966, Dec 15:3153-3171.
107. Wiener H. External chemical messengers, II. Natural history of schizophrenia. NY State J. Med. 1967, May 1:1144-1151.
108. Wu J., Buschbaum M.S., Moy K., Denlea N., Kesslak P., Tseng H., Plosnaj D., Hetu M., Potkin S., Bracha S., Cotman C. Olfactory memory in unmedicated schizophrenics. Schizophr. Res. 1993, 9:41-47.
109. Wysocki C.J., Beauchamp G.K. Ability to smell androstenone is genetically determined. Proc. Natl. Acad. Sci. USA 1984, 81:4899-4902.
110. Wysocki C.J., Gilbert A.N. National Geographic Smell Survey: The effects of age are heterogeneous. Ann. NY Acad. Sci. 1987, 12-28. In Part 1. Characterisation of chemosensory changes in aging.
111. Wysocki C.J., Dorries K,M., Beauchamp G.K. Ability to perceive androstenone can be acquired by ostensibly anosmic people. P. Nat. Acad. Sci. 1989, 86:7976-7978.
112. Zatorre R.J., Jones-Gotman M., Evans A.C., Meyer E. Functional localisation and lateralisation of human olfactory cortex. Nature 1992, 360:339-340.